Kenneth A. Bauer
Corporate Officer/Principal en The International Society of Thrombosis & Hemostasis .
Cargos activos de Kenneth A. Bauer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The International Society of Thrombosis & Hemostasis | Corporate Officer/Principal | - | - |
Historial de carrera de Kenneth A. Bauer
Antiguos cargos conocidos de Kenneth A. Bauer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REVO BIOLOGICS INC | Director/Miembro de la Junta | 01/12/2004 | 01/10/2009 |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/1997 | - |
Formación de Kenneth A. Bauer.
| Massachusetts Institute of Technology | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorial
| Finance | 2 |
| Health Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
| The International Society of Thrombosis & Hemostasis | |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Kenneth A. Bauer
- Experiencia
